- Factors associated with receipt of prescription medication for menopause-related symptoms. [Journal Article]Menopause. 2026 Oct 27. [Online ahead of print]M
- CONCLUSIONS: Our study demonstrates differential prescribing patterns for menopause-related symptoms with respect to race, insurance status, and clinician specialty. Our results underscore the need for equitable care for women experiencing menopause symptoms.
- Publisher Full Text (DOI)
- Bothersome VMS associated with menopause: a survey of the impact on women and their partners in the United States. [Journal Article]Menopause. 2026 Oct 20. [Online ahead of print]M
- CONCLUSIONS: VMS have the potential to reduce relationship satisfaction for women and for their partners. Although women and partners were generally aligned on the daily life impact of VMS, there were problems with communication and gaps in perception. Furthermore, most women had never received treatment for VMS. This suggests an unmet need for educational programs and highlights the importance of enhancing communication between women experiencing VMS and their health care professionals.
- Publisher Full Text (DOI)
- Unmasking the midnight thief: how menopausal vasomotor symptoms shape aging women's brain health. [Journal Article]Menopause. 2026 Oct 20. [Online ahead of print]M
- Publisher Full Text (DOI)
- Natural, clean, yet still allergenic: contact allergen burden in vulvar soothing products. [Journal Article]Menopause. 2026 Oct 20. [Online ahead of print]M
- CONCLUSIONS: Most nonhormonal vulvar soothing products contain common contact allergens despite marketing suggesting improved tolerability. These findings support ingredient-based counseling by Menopause Society Certified Practitioners and other menopause health care professionals when recommending over-the-counter vulvar products to minimize contact allergen exposure and contact dermatitis risk.
- Publisher Full Text (DOI)
- Lifestyle factors associated with hot flash frequency and daily interference: highlighting the role of sleep quality, diet quality and physical activity. [Journal Article]Menopause. 2026 Oct 20. [Online ahead of print]M
- CONCLUSIONS: Findings suggest the importance of routine sleep quality for symptom burden and may inform lifestyle-focused approaches to symptom management.
- Publisher Full Text (DOI)
- Regular physical activity is associated with lower odds of bodily pain in midlife women. [Journal Article]Menopause. 2026 Oct 13. [Online ahead of print]M
- CONCLUSIONS: Regular physical activity is independently associated with lower odds of bodily pain in midlife women. Exercise programs, in combination with MHT, may contribute to optimizing pain management in this population and warrant further prospective investigation.
- Publisher Full Text (DOI)
- Menopausal hormone therapy combined with antiresorptive therapy for skeletal outcomes in postmenopausal women: a systematic review and network meta-analysis of randomized controlled trials. [Journal Article]Menopause. 2026 Oct 13. [Online ahead of print]M
- CONCLUSIONS: In postmenopausal women, systemic MHT, bisphosphonate therapy, and their combination improved BMD compared with control. Combination MHT plus bisphosphonate therapy showed the most favorable hip-region BMD profile; however, current evidence is insufficient to establish superior fracture prevention or long-term safety.
- Publisher Full Text (DOI)
- Premature menopause and risk of type 2 diabetes among postmenopausal women: findings from the Women's Health Initiative. [Journal Article]Menopause. 2026 Oct 13. [Online ahead of print]M
- CONCLUSIONS: Premature menopause was modestly associated with an increased T2D risk; this association varied by HT use and was partially mediated by BMI.
- Publisher Full Text (DOI)
- Trends of menopausal hormone therapy across Canadian provinces in 2018-2023. [Journal Article]Menopause. 2026 Oct 13. [Online ahead of print]M
- CONCLUSIONS: MHT use in Canada is increasing but remains modest and variable across formulations and provinces. Markedly higher use of MHT in Quebec may be partly explained by a more comprehensive drug coverage. Our findings highlight gaps in uptake of guideline-recommended therapy and provide a foundation for future research and policy considerations.
- Publisher Full Text (DOI)
- Quantitative assessment of neurokinin receptor antagonists in menopausal hot flashes: a model-based meta-analysis. [Journal Article]Menopause. 2026 Oct 13. [Online ahead of print]M
- CONCLUSIONS: Fezolinetant (45 mg) and elinzanetant (120 mg) demonstrated comparable efficacy for menopausal hot flashes. Model-based indirect comparisons provided clinical context for interpreting their efficacy relative to other hormone and nonhormone therapies. This study provides quantitative evidence to inform medication selection and pharmacoeconomic evaluations in women with menopausal hot flashes.
- Publisher Full Text (DOI)
- Effects of adherence to a Mediterranean diet on body weight in postmenopausal women: a systematic review. [Journal Article]Menopause. 2026 Oct 13. [Online ahead of print]M
- CONCLUSIONS: The different design, limited number of studies and their small sample sizes may have limited the strength of evidence, making the detection of long-term benefits difficult. In qualitative synthesis, the included studies showed mixed findings, with no consistent superiority of MedDiet across weight, fat mass, or lean mass outcomes. MedDiet counseling alone, without explicit energy restriction or other structured weight-management strategies, should not be assumed to produce clinically meaningful reductions in body weight or fat mass.
- Publisher Full Text (DOI)
- The effectiveness of physical activity interventions on non-physiological symptoms of menopause: a systematic review and meta-analysis. [Journal Article]Menopause. 2026 Oct 13. [Online ahead of print]M
- CONCLUSIONS: PA may seem to improve depression, mood, and QoL in women in the MT. Both ABIs and MBIs may be beneficial, supporting the integration of PA into clinical care for menopausal women. Further high-quality trials with clearer menopause staging are needed to strengthen the evidence base.
- Publisher Full Text (DOI)
- Reproductive history and age at natural menopause in US women: a cross-sectional analysis of National Health and Nutrition Examination Survey 1999 to March 2020. [Journal Article]Menopause. 2026 Oct 06. [Online ahead of print]M
- CONCLUSIONS: Higher gravidity showed a small, nonconfirmatory association with later ANM at moderate exposure levels. The findings do not support a robust nonlinear relationship or a simple cumulative ovulation-sparing model.
- Publisher Full Text (DOI)
- Associations of psychosocial supports and stressors with cognition in midlife women. [Journal Article]Menopause. 2026 Oct 06. [Online ahead of print]M
- CONCLUSIONS: Financial and food insecurity, but not social support, perceived stress, or discrimination, were associated with poorer memory, executive function, and attention in midlife women.
- Publisher Full Text (DOI)
- From black box warning to wake-up call: menopausal hormone therapy prescribing patterns at a large academic medical center. [Journal Article]Menopause. 2026 Oct 06. [Online ahead of print]M
- CONCLUSIONS: MHT prescribing remained persistently low over 18 years, with significant racial disparities, lower prescribing among women with greater comorbidity burden, and differences associated with insurance coverage. These findings highlight a sustained gap between evidence-based recommendations and real-world menopause care and may suggest that both clinical and structural factors may influence access to treatment.
- Publisher Full Text (DOI)